carvedilol has been researched along with Primary Peritonitis in 1 studies
Excerpt | Relevance | Reference |
---|---|---|
"Carvedilol (CVL) is an α-, β-blocker used to treat high blood pressure and congestive heart failure; however, some benefits beyond decreased blood pressure were observed clinically, suggesting the potential anti-inflammatory activity of CVL." | 1.48 | Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome. ( Chen, A; Cheng, CC; Cheng, SM; Hua, KF; Li, LH; Lin, WY; Rao, YK; Wong, WT; Yang, SP, 2018) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wong, WT | 1 |
Li, LH | 1 |
Rao, YK | 1 |
Yang, SP | 1 |
Cheng, SM | 1 |
Lin, WY | 1 |
Cheng, CC | 1 |
Chen, A | 1 |
Hua, KF | 1 |
1 other study available for carvedilol and Primary Peritonitis
Article | Year |
---|---|
Repositioning of the β-Blocker Carvedilol as a Novel Autophagy Inducer That Inhibits the NLRP3 Inflammasome.
Topics: Adrenergic beta-Antagonists; Animals; Autophagy; Carvedilol; Cell Line; Cytokines; Disease Models, A | 2018 |